Repare Therapeutics Inc (RPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 6,877 | 278 | 279 | 166 | 0 |
| Gross Profit | 6,877 | 278 | 279 | 166 | N/A |
| Operating Expenses | 35,611 | 31,957 | 26,946 | 21,746 | 17,212 |
| Operating Income | -28,734 | -31,679 | -26,667 | -21,580 | -17,077 |
| Other Income | 32 | 79 | -63 | 26 | 260 |
| Pre-tax Income | -28,702 | -31,600 | -26,730 | -21,554 | -16,817 |
| Income Tax | -412 | -708 | -421 | -137 | -1,554 |
| Net Income Continuous | -28,290 | -30,892 | -26,309 | -21,417 | -15,263 |
| Net Income | $-28,290 | $-30,892 | $-26,309 | $-21,417 | $-15,263 |
| EPS Basic Total Ops | -0.71 | -0.83 | -0.71 | -0.58 | 7.87 |
| EPS Basic Continuous Ops | -0.70 | -0.83 | -0.71 | -0.58 | 7.87 |
| EPS Diluted Total Ops | -0.71 | -0.83 | -0.71 | -0.58 | 7.87 |
| EPS Diluted Continuous Ops | -0.70 | -0.83 | -0.71 | -0.58 | 7.87 |
| EBITDA(a) | $-28,338 | $-31,279 | $-26,230 | $-21,229 | $-16,925 |